Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion
-
Pernix Announces Appointment of Lead Independent Director and Key Management Team Promotion
-
Centene (CNC) PT Raised to $125 at Cantor Fitzgerald on 4Q Report; 'Raises 2018 Guidance... Outlook Strengthens'
-
OncoSec Medical Incorporated Announces Closing of $23.0 Million Public Offering of Common Stock
-
Equity Residential (EQR) PT Lowered to $66 at Cantor Fitzgerald
-
GW Pharma (GWPH) PT Lowered to $192 at Cantor Fitzgerald
-
Cellular Biomedicine Group (CBMG) Reports $30.6M Investment from Sailing Capital Overseas Investment Ltd.
-
Cellular Biomedicine Group Announces $30.6 million Investment from Sailing Capital Overseas Investment Ltd.
-
Cellular Biomedicine Group Announces $30.6 million Investment from Sailing Capital Overseas Investment Ltd.
-
EastGroup Properties (EGP) PT Raised to $86 at Cantor Fitzgerald Following Earnings Report
-
Prothena Corp. (PRTA): PRONTO Trial Could Offset Optics Of CMO Resignation - Cantor Fitzgerald
-
athenahealth (ATHN) PT Raised to $130 at Cantor Fitzgerald
-
AvalonBay Communities (AVB) PT Lowered to $185 at Cantor Fitzgerald Following Model Adjustment to Update for Q4
-
Alibaba (BABA) PT Raised to $270 at Cantor Fitzgerald
-
Oncosec Medical (ONCS) Prices $20M Public Offering of Common Stock
-
OncoSec Medical Incorporated Prices $20.0 Million Public Offering of Common Stock
-
Oncosec Medical (ONCS) Plans Public Offering of Common Stock
-
OncoSec Medical Incorporated Announces Proposed Public Offering of Common Stock
-
Equity LifeStyle Properties (ELS) PT Raised to $85 at Cantor Fitzgerald
-
Aetna (AET) PT Raised to $211 at Cantor Fitzgerald To Better Reflect The Pending Merger With CVS (CVS)
-
HCA Holdings (HCA) PT Raised to $115 at Cantor Fitzgerald
-
Bellicum Pharmaceuticals (BLCM) PT Lowered to $10 at Cantor Fitzgerald, Keeps 'OW' Following Clinical Hold
-
ProPhotonix Announces its Fiscal 2017 Trading Update
-
Cantor Fitzgerald Upgrades Castlight Health Inc. (CSLT) to Overweight Amid Sell-Off
-
Gemini Rosemont adds Meehan and Frandson to leadership team
-
Cerner (CERN) Gains as Health Sector Rocked on Amazon Foray
-
Amarin Corp. (AMRN) Prices Common Stock Offering for $70M in Gross Proceeds
-
Amarin Prices Public Offering of American Depositary Shares
-
Amarin Prices Public Offering of American Depositary Shares
-
ELS Reports Fourth Quarter Results
-
Amarin Corp. (AMRN) Plans Public Offering of American Depositary Shares
-
Amarin Announces Proposed Public Offering of American Depositary Shares
-
Amarin Announces Proposed Public Offering of American Depositary Shares
-
ProPhotonix New High-Performance PROdigii
-
Strongbridge Biopharma (SBBP) Prices 5M Offering of Ordinary Shares at $6.75/Share
-
Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares
-
Form 13F-HR CANTOR FITZGERALD INVEST For: Dec 31
-
ProLogis (PLD) PT Raised to $70 at Cantor Fitzgerald
-
Aerie Pharma (AERI) Prices $75M Common Share Offering
-
Aerie Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Strongbridge Biopharma (SBBP) Plans Offering of 5M Ordinary Shares
-
Strongbridge Biopharma plc Announces Proposed Public Offering of 5 Million Ordinary Shares
-
Aerie Pharma (AERI) to Offer $75M in Common Stock
-
Aerie Pharmaceuticals Announces Public Offering of Common Stock
-
HTG Molecular Diagnostics Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Amarin Corp. (AMRN): Stock Has Room To Run Ahead of Data - Cantor
-
Arrowhead Pharmaceuticals Closes Underwritten Public Offering with Gross Proceeds of $60.4 Million
-
TipRanks Identifies the Top 20 Analysts of 2017
-
Worldplay Inc. (WP) PT Raised to $89 at Cantor Fitzgerald
-
Valeant (VRX) Defended at Cantor Fitzgerald Amd Cosmo Competition Fears

